Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
RAS AL KHAIMAH ? As the UAE comes second worldwide after the Narushima Island in terms of the number of diabetics, the Gulf Pharmaceutical Industries (Julphar) will start producing the raw material for Insulin by the end of the year, and be involved in regionally expansive care campaigns.
According to a top official here, diabetes rates in the Middle East and North Africa are among the highest in the world, and the chronic disease has hit millions of people around the world.
Shaikh Faisal bin Sager Al Qassimi, Chairman of Julphar, said the company, therefore, is finishing work on a Ras Al Khaimah-based biotechnology plant worth Dh500 million, for commercially producing the strategic medication by the beginning of 2012.
?The first of its kind factory in the Middle East will annually produce 1,500kg and 50 million vials of the raw material for Insulin which is responsible for regulating carbohydrate and fat metabolism in the body,? said Shaikh Faisal, who is also the Chairman of the RAK Free Zone.
http://www.khaleejtimes.com/Display...December/theuae_December95.xml§ion=theuae
According to a top official here, diabetes rates in the Middle East and North Africa are among the highest in the world, and the chronic disease has hit millions of people around the world.
Shaikh Faisal bin Sager Al Qassimi, Chairman of Julphar, said the company, therefore, is finishing work on a Ras Al Khaimah-based biotechnology plant worth Dh500 million, for commercially producing the strategic medication by the beginning of 2012.
?The first of its kind factory in the Middle East will annually produce 1,500kg and 50 million vials of the raw material for Insulin which is responsible for regulating carbohydrate and fat metabolism in the body,? said Shaikh Faisal, who is also the Chairman of the RAK Free Zone.
http://www.khaleejtimes.com/Display...December/theuae_December95.xml§ion=theuae